Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

ClinicalTrials.gov ID: NCT04116437

Public ClinicalTrials.gov record NCT04116437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients With Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment With Ibrutinib and/or Acalabrutinib

Study identification

NCT ID
NCT04116437
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
BeiGene
Industry
Enrollment
96 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 14, 2019
Primary completion
Jan 8, 2026
Completion
Jan 8, 2026
Last update posted
Jan 27, 2026

2019 – 2026

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Rocky Mountain Cancer Centers (Williams) Usor Aurora Colorado 80012-5405
Christiana Care Newark Delaware 19713-2055
Scri Florida Cancer Specialists South Fort Myers Florida 33901-8108
St Century Oncology Jacksonville Florida 32204-1128
Scri Florida Cancer Specialists North St. Petersburg Florida 33705-1449
Healthcare Research Network Iii, Llc Flossmoor Illinois 60422-2067
Minnesota Oncology Burnsville Clinic Burnsville Minnesota 55337-6749
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169-3321
Summit Medical Group Florham Park New Jersey 07932-1049
Morristown Medical Center Morristown New Jersey 07960-6136
Clinical Research Alliance, Inc Westbury New York 11590-5119
Oncology Associates of Oregon Willamette Valley Cancer Center Eugene Oregon 97401
St Lukes University Health Network Fountain Hill Pennsylvania 18015-1153
Abington Hematology Oncology Associates Horsham Pennsylvania 19044-2331
Tennessee Oncology, Pllc Nashville Nashville Tennessee 37203
Texas Oncology Amarillo Amarillo Texas 79106-1781
Texas Oncology Tyler Longview Austin Texas 78705-1163
Baylor Research Institute Dallas Texas 75246-2079
Texas Oncology McAllen South Second Street McAllen Texas 78503
Us Oncology Virginia Cancer Specialists, Pc Fairfax Virginia 22031-4629
Virginia Oncology Associates Norfolk Virginia 23502-2800
Fred Hutchinson Cancer Research Center Seattle Washington 98109-4433
Medical Oncology Associates Spokane Washington 99208-1129
Ssm Health Cancer Care Dean Medical Center Madison Wisconsin 53717-1959

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04116437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04116437 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →